GPER agonist G-1 decreases adrenocortical carcinoma (ACC) cell growth in vitro and in vivo

We have previously demonstrated that estrogen receptor (ER) alpha (ESR1) increases proliferation of adrenocortical carcinoma (ACC) through both an estrogen-dependent and -independent (induced by IGF-II/IGF1R pathways) manner. Then, the use of tamoxifen, a selective estrogen receptor modulator (SERM)...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Oncotarget
Hlavní autoři: Chimento, Adele, Sirianni, Rosa, Casaburi, Ivan, Zolea, Fabiana, Rizza, Pietro, Avena, Paola, Malivindi, Rocco, De Luca, Arianna, Campana, Carmela, Martire, Emilia, Domanico, Francesco, Fallo, Francesco, Carpinelli, Giulia, Cerquetti, Lidia, Amendola, Donatella, Stigliano, Antonio, Pezzi, Vincenzo
Médium: Artigo
Jazyk:Inglês
Vydáno: Impact Journals LLC 2015
Témata:
Research Paper
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4662484/
https://ncbi.nlm.nih.gov/pubmed/26131713
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky